Repaglinide (Citron Pharma LLC)
Welcome to the PulseAid listing for the Repaglinide drug offered from Citron Pharma LLC. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Citron Pharma LLC |
NON-PROPRIETARY NAME: | Repaglinide |
SUBSTANCE NAME: | REPAGLINIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-01-22 |
END MARKETING DATE: | 0000-00-00 |
Repaglinide HUMAN PRESCRIPTION DRUG Details:
Item Description | Repaglinide from Citron Pharma LLC |
LABELER NAME: | Citron Pharma LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2014-01-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57237-157_d7673e22-0dbb-4395-ad60-943d249203a1 |
PRODUCT NDC: | 57237-157 |
APPLICATION NUMBER: | ANDA203820 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers: